文献速递主动脉疾病

开胸胸腹主动脉瘤修复术中自动化压力控制脑脊液引流的安全性与有效性

Automated pressure-controlled cerebrospinal fluid drainage during open thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-02-16

该回顾性研究纳入152例开胸胸腹主动脉瘤修复术患者,比较传统滴壶式脑脊液引流与LiquoGuard自动化装置的效果。结论认为LiquoGuard安全有效。

要点

  • LiquoGuard自动化脑脊液引流在胸腹主动脉瘤开胸修复术中安全有效。
  • 自动化组术中脑脊液压力轻度升高,但脊髓缺血发生率未增加。
  • 自动化组硬脊膜穿刺后头痛发生率显著降低(3.3% vs 16.9%)。

核心结论

  • 胸腹主动脉瘤开胸修复术中围术期使用LiquoGuard自动化脑脊液引流装置安全有效。
  • 尽管自动化组术中脑脊液压力轻度升高,但脊髓缺血发生率未增加,且硬脊膜穿刺后头痛显著减少。

研究设计与样本

  • 传统滴壶式系统组73例,LiquoGuard自动化装置组79例;系统选择按1:1随机交替直至最后6例连续使用LiquoGuard。
  • 主要结局为脊髓缺血、颅内出血、硬脊膜穿刺后头痛及院内死亡的发生率。

主要发现

  • 在干预开始时(T1)和手术结束后4小时(T5),两组脑脊液压力值无显著差异。
  • 重复测量方差分析显示,自动化组在主动脉阻断后15分钟(T2)、松开阻断前(T3)和手术结束时(T4)脑脊液压力呈显著上升趋势(组×时间交互作用F3,66;P < .001)。
  • 脊髓缺血、颅内出血或死亡率两组间无差异。
  • LiquoGuard组硬脊膜穿刺后头痛发生率显著降低(3.3% vs 16.9%;P = .01)。

临床怎么用

  • 在开胸胸腹主动脉瘤修复术中,可考虑使用LiquoGuard自动化装置进行围术期脑脊液引流,以维持目标压力并减少不必要的引流。
  • 使用该装置时术中脑脊液压力可能轻度升高,但未增加脊髓缺血风险,且可降低硬脊膜穿刺后头痛发生率。

局限性

  • 本研究为单中心回顾性设计,样本量有限(152例),可能存在选择偏倚。
  • 引流系统的选择虽按1:1随机交替,但并非完全随机化,且未报告盲法。
  • 研究仅比较了两种装置,未评估其他自动化系统的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Perioperative cerebrospinal fluid (CSF) drainage is a well-established technique for spinal cord protection during thoracoabdominal aortic aneurysm (TAAA) open repair and is usually performed using dripping chamber-based systems. A new automated device for controlled and continuous CSF drainage, designed to maintain CSF pressure around the desired set values, thus avoiding unnecessary drainage, is currently available. The aim of our study was to determine whether the use of the new LiquoGuard automated device (Möller Medical GmbH, Fulda, Germany) during TAAA open repair was safe and effective in maintaining the desired CSF pressure values and whether the incidence of complications was reduced compared with a standard catheter connected to a dripping chamber. METHODS: Data of patients who underwent surgical TAAA open repair using perioperative CSF drainage at our institution between October 2012 and October 2014 were recorded. The difference in CSF pressure values between patients who underwent CSF drainage with a conventional dripping chamber-based system (manual group) and patients who underwent CSF drainage with the LiquoGuard (automated group) was measured at the beginning of the intervention (T1), 15 minutes after aortic cross-clamping (T2), just before unclamping (T3), at the end of surgery (T4), and 4 hours after the end of surgery (T5). The choice of the draining systems was randomly alternated with one-to-one rate until the last six patients consecutively treated with LiquoGuard were enrolled. Primary outcomes were occurrence of spinal cord ischemia, intracranial hemorrhage, postdural puncture headache, and in-hospital mortality. RESULTS: The study included 152 patients who underwent open surgical TAAA repair during the study period: 73 patients underwent CSF drainage with the traditional system and 79 with LiquoGuard. The CSF pressure values at T1 and T5 were not considerably different in the two groups. By repeated-measures analysis of variance, a significant upward trend of perioperative CSF pressure was observed in the automated group at T2, T3, and T4 (group × time interaction = F3,66; P < .001). No difference was reported in the occurrence of spinal cord ischemia, intracranial hemorrhage, or mortality. The LiquoGuard group reported significantly reduced postdural puncture headache (3.3% vs 16.9%; P = .01). CONCLUSIONS: Perioperative use of LiquoGuard during TAAA open repair was safe and effective. Despite slightly higher intraoperative CSF pressures, the rate of spinal cord ischemia did not increase in the LiquoGuard group, and postdural puncture headache significantly decreased.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tshomba Y, Leopardi M, Mascia D, et al. Automated pressure-controlled cerebrospinal fluid drainage during open thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28216365. doi:10.1016/j.jvs.2016.11.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。